Skip to main content
OpenTrials

Clinical trial condition

Hematologic Neoplasms

Explore clinical trials studying Hematologic Neoplasms. Study availability and eligibility vary by location and protocol.

1,027 public trials 268 recruiting studies
Refine in advanced search Browse all conditions

Hematologic Neoplasms trial results

Recruiting

Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies

NCT05476770

Conditions
ALL, AML, Acute Undifferentiated Leukemia, +30 more
Locations
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • Children's Hospital Orange County Orange, California, United States
  • UCSF School of Medicine San Francisco, California, United States
  • Children's Hospital Colorado Denver, Colorado, United States
View all 31 locations
View Trial Details
Recruiting

Study of VIP943 in Subjects With Advanced CD123+ Hematologic Malignancies

NCT06034275

Conditions
Acute Myeloid Leukemia, B-cell Acute Lymphoblastic Leukemia, Bone Marrow Diseases, +24 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • University of Cincinnati Cincinnati, Ohio, United States
  • TriStar Bone Marrow Transplant Nashville, Tennessee, United States
  • MD Anderson Cancer Center Houston, Texas, United States
View Trial Details
Recruiting

A Study of HDM2005 in Patients With Relapsed/Refractory B-cell Lymphoma and Advanced Solid Tumor

NCT06615193

Conditions
Advanced Solid Tumors, Hematologic Diseases, Hematologic Neoplasms, +11 more
Locations
  • Henan Cancer Hospital Zhengzhou, Henan, China
  • The First Affiliated Hospital of Soochow University Suzhou, Jiangsu, China
  • The Second Affiliated Hospital of Soochow University Suzhou, Jiangsu, China
  • The Affiliated Hospital of Xuzhou Medical University Xuzhou, Jiangsu, China
View Trial Details

Related conditions